Ionis Pharmaceuticals (IONS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS)

IONS 82.67

-1.4%

Jan 30 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Perry who wrote (1898)	4/7/1998 1:42:00 AM
From: tom jones	Read Replies (1) of 4676

To all: Can someone explain this part of the Fomivirsen press release? "Results from trials in both newly-diagnosed patients and patients with advanced disease showed that fomivirsen produced prolonged delay in progression of CMV retinitis, with similar median times to progression (71 days in newly-diagnosed patients, 90 days in patients with advanced disease)." Does CMV retinitis progress even if fomivirsen is used? Does it progress to blindness when fomivirsen is used? I thought fomivirsen stopped the progression of CMV retintis from earlier press releases I read on this drug. Comments? Tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next